Each Delphi partner has experience in one or more of our core investment areas of medical devices and biotechnology. Depending on the nature of the deal, one partner takes the lead in meeting with the team and investigating the opportunity, but it is not unusual for four or five partners to participate in the due diligence process. If it is of interest, we invite the company to present to the partnership. Every Delphi partner is a decision-maker and no one partner has "veto" power. All investments are carefully reviewed, discussed and debated. Then, together, we commit to move forward.